Misconceptions and Facts About Treating Hypertension

American Journal of Medicine

Volumn 128, Issue 5, 2015, Pages 450-455

  Argulian, Edgar ^a   Grossman, Ehud ^b   Messerli, Franz H ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Antihypertensive therapy; Hypertension; J curve

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT; CHLORTALIDONE; INDAPAMIDE;

ADRENERGIC ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; THERAPEUTIC MISCONCEPTION; DRUG EFFECTS; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHLORTHALIDONE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDAPAMIDE; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84929042942     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.11.015     Document Type: Review

References (56)

1. E.S. Ford Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States Circulation 123 2011 1737 1744
2. B.M. Egan, Y. Zhao, and R.N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
3. P.A. James, S. Oparil, B.L. Carter, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
4. F.H. Messerli, and S. Bangalore Half a century of hydrochlorothiazide: facts, fads, fiction, and follies Am J Med 124 2011 896 899
5. F.H. Messerli, H. Makani, A. Benjo, et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials J Am Coll Cardiol 57 2011 590 600
6. B.L. Carter, M.E. Ernst, and J.D. Cohen Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability Hypertension 43 2004 4 9
7. J.D. Finkielman, G.L. Schwartz, A.B. Chapman, et al. Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide Am J Hypertens 18 2005 398 402
8. D.S. Siscovick, T.E. Raghunathan, B.M. Psaty, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest N Engl J Med 330 1994 1852 1857
9. K. Jamerson, M.A. Weber, G.L. Bakris, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
10. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group JAMA 265 1991 3255 3264
11. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
12. N.S. Beckett, R. Peters, A.E. Fletcher, et al. Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898
13. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
14. R. Woodman, C. Brown, and W. Lockette Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis Hypertension 56 2010 463 470
15. T. Krause, K. Lovibond, M. Caulfield, et al. Management of hypertension: summary of NICE guidance BMJ 343 2011 d4891
16. R. Agarwal, and A.D. Sinha Thiazide diuretics in advanced chronic kidney disease J Am Soc Hypertens 6 2012 299 308
17. R. Agarwal, A.D. Sinha, M.K. Pappas, and F. Ammous Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study Am J Nephrol 39 2014 171 182
18. M. Esler, E. Lambert, and M. Schlaich Point: chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension J Appl Physiol (1985) 109 2010 1996 1998 discussion 2016
19. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group JAMA 283 2000 1967 1975
20. C.J. Lavie, F.H. Messerli, and R.V. Milani Beta-blockers as first-line antihypertensive therapy the crumbling continues J Am Coll Cardiol 54 2009 1162 1164
21. S. Bangalore, F.H. Messerli, J.B. Kostis, and C.J. Pepine Cardiovascular protection using beta-blockers: a critical review of the evidence J Am Coll Cardiol 50 2007 563 572
22. S. Bangalore, S. Parkar, E. Grossman, and F.H. Messerli A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus Am J Cardiol 100 2007 1254 1262
23. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, et al. A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
24. F.H. Messerli, and S. Bangalore Renal denervation for resistant hypertension? N Engl J Med 370 2014 1454 1457
25. J. Menard, D.J. Campbell, M. Azizi, and M.F. Gonzales Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats Circulation 96 1997 3072 3078
26. M.M. Givertz Manipulation of the renin-angiotensin system Circulation 104 2001 E14 E18
27. F.H. Messerli, J.A. Staessen, and F. Zannad Of fads, fashion, surrogate endpoints and dual RAS blockade Eur Heart J 31 2010 2205 2208
28. J.J. McMurray, S. Adamopoulos, S.D. Anker, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
29. Standards of medical care in diabetes-2012 Diabetes Care 35 Suppl 1 2012 S11 S63
30. H. Makani, S. Bangalore, K.A. Desouza, et al. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials BMJ 346 2013 f360
31. B. Pitt, F. Zannad, W.J. Remme, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
32. G. Shlomai, T. Sella, Y. Sharabi, et al. Serum potassium levels predict blood pressure response to aldosterone antagonists in resistant hypertension Hypertens Res 37 2014 1037 1041
33. S. Bangalore, S. Kumar, and F.H. Messerli When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist? Congest Heart Fail 19 2013 107 115
34. F.H. Messerli Vasodilatory edema: a common side effect of antihypertensive therapy Curr Cardiol Rep 4 2002 479 482
35. M.R. Weir, C. Rosenberger, and J.C. Fink Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists Am J Hypertens 14 9 Pt 1 2001 963 968
36. H. Makani, S. Bangalore, J. Romero, et al. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Am J Med 124 2011 128 135
37. K.P. Nunes, H. Labazi, and R.C. Webb New insights into hypertension-associated erectile dysfunction Curr Opin Nephrol Hypertens 21 2012 163 170
38. R. Kloner Erectile dysfunction and hypertension Int J Impot Res 19 2007 296 302
39. C. Costa, and R. Virag The endothelial-erectile dysfunction connection: an essential update J Sex Med 6 2009 2390 2404
40. I.M. Thompson, C.M. Tangen, P.J. Goodman, et al. Erectile dysfunction and subsequent cardiovascular disease JAMA 294 2005 2996 3002
41. R.H. Grimm Jr., G.A. Grandits, R.J. Prineas, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension 29 1 Pt 1 1997 8 14
42. D.T. Ko, P.R. Hebert, C.S. Coffey, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction JAMA 288 2002 351 357
43. K. Brixius, M. Middeke, A. Lichtenthal, et al. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men Clin Exp Pharmacol Physiol 34 2007 327 331
44. M. Doumas, and S. Douma The effect of antihypertensive drugs on erectile function: a proposed management algorithm J Clin Hypertens (Greenwich) 8 2006 359 364
45. M. Doumas, M. Viigimaa, and V. Papademetriou Combined antihypertensive therapy and sexual dysfunction: terra incognita Cardiology 125 2013 232 234
46. R.A. Kloner, M. Brown, L.M. Prisant, and M. Collins Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group Am J Hypertens 14 2001 70 73
47. G.S. Panjrath, S. Chaudhari, and F.H. Messerli The j-point phenomenon in aggressive therapy of hypertension: new insights Curr Atheroscler Rep 14 2012 124 129
48. F.H. Messerli, G. Mancia, C.R. Conti, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144 2006 884 893
49. R.S. Vasan, M.G. Larson, E.P. Leip, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease N Engl J Med 345 2001 1291 1297
50. M. Banach, and W.S. Aronow Blood pressure j-curve: current concepts Curr Hypertens Rep 14 2012 556 566
51. N.M. Kaplan The diastolic J curve: alive and threatening Hypertension 58 2011 751 753
52. A. Zanchetti Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve Eur Heart J 31 2010 2837 2840
53. S. Bangalore, Y. Gong, R.M. Cooper-DeHoff, et al. 2014 Eighth Joint National Committee Panel Recommendation for Blood Pressure Targets Revisited: Results From the INVEST Study J Am Coll Cardiol 64 2014 784 793
54. W.C. Cushman, G.W. Evans, R.P. Byington, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
55. R.M. Cooper-DeHoff, Y. Gong, E.M. Handberg, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease JAMA 304 2010 61 68
56. W.T. Ambrosius, K.M. Sink, C.G. Foy, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) Clin Trials 11 2014 532 546